Co‐administered semaglutide and glucose‐dependent insulinotropic peptide receptor agonist compared with monotherapies and placebo in people with type 2 diabetes: a randomised, dose‐finding, phase 2 trial

Filip Krag Knop; Debora P.  Cabral; Juan P Frias; Manjunatha  Revanna; Anette L.  Søndergaard; Vanita R Aroda

doi:10.1089/dia.2024.2525.abstracts

Co‐administered semaglutide and glucose‐dependent insulinotropic peptide receptor agonist compared with monotherapies and placebo in people with type 2 diabetes: a randomised, dose‐finding, phase 2 trial

Filip Krag Knop, Debora P. Cabral, Juan P Frias, Manjunatha Revanna, Anette L. Søndergaard, Vanita R Aroda

Originalsprog	Engelsk
Artikelnummer	O023 / #680
Tidsskrift	Diabetes Technology & Therapeutics
Vol/bind	26
Udgave nummer	s2
ISSN	1520-9156
DOI	https://doi.org/10.1089/dia.2024.2525.abstracts
Status	Udgivet - feb. 2024
Begivenhed	ATTD 2024 - 17th International Conference on Advanced Technologies & Treatments for Diabetes - Florence, Italien Varighed: 6 mar. 2024 → 9 mar. 2024 https://attd.kenes.com/

Konference

Konference	ATTD 2024 - 17th International Conference on Advanced Technologies & Treatments for Diabetes
Land/Område	Italien
By	Florence
Periode	06/03/2024 → 09/03/2024
Internetadresse	https://attd.kenes.com/

Adgang til dokumentet

10.1089/dia.2024.2525.abstracts

Citationsformater

Knop, F. K., Cabral, D. P., Frias, J. P., Revanna, M., Søndergaard, A. L., & Aroda, V. R. (2024). Co‐administered semaglutide and glucose‐dependent insulinotropic peptide receptor agonist compared with monotherapies and placebo in people with type 2 diabetes: a randomised, dose‐finding, phase 2 trial. Diabetes Technology & Therapeutics, 26(s2), Artikel O023 / #680 . https://doi.org/10.1089/dia.2024.2525.abstracts

Co‐administered semaglutide and glucose‐dependent insulinotropic peptide receptor agonist compared with monotherapies and placebo in people with type 2 diabetes: a randomised, dose‐finding, phase 2 trial. / Knop, Filip Krag; Cabral, Debora P. ; Frias, Juan P et al.
I: Diabetes Technology & Therapeutics, Bind 26, Nr. s2, O023 / #680 , 02.2024.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Knop, FK, Cabral, DP, Frias, JP, Revanna, M, Søndergaard, AL & Aroda, VR 2024, 'Co‐administered semaglutide and glucose‐dependent insulinotropic peptide receptor agonist compared with monotherapies and placebo in people with type 2 diabetes: a randomised, dose‐finding, phase 2 trial', Diabetes Technology & Therapeutics, bind 26, nr. s2, O023 / #680 . https://doi.org/10.1089/dia.2024.2525.abstracts

Knop FK, Cabral DP, Frias JP, Revanna M, Søndergaard AL, Aroda VR. Co‐administered semaglutide and glucose‐dependent insulinotropic peptide receptor agonist compared with monotherapies and placebo in people with type 2 diabetes: a randomised, dose‐finding, phase 2 trial. Diabetes Technology & Therapeutics. 2024 feb.;26(s2):O023 / #680 . doi: 10.1089/dia.2024.2525.abstracts

@article{1e70ac11cdd040928236452bc3bc4551,

title = "Co‐administered semaglutide and glucose‐dependent insulinotropic peptide receptor agonist compared with monotherapies and placebo in people with type 2 diabetes: a randomised, dose‐finding, phase 2 trial",

author = "Knop, {Filip Krag} and Cabral, {Debora P.} and Frias, {Juan P} and Manjunatha Revanna and S{\o}ndergaard, {Anette L.} and Aroda, {Vanita R}",

year = "2024",

month = feb,

doi = "10.1089/dia.2024.2525.abstracts",

language = "English",

volume = "26",

journal = "Diabetes Technology & Therapeutics",

issn = "1520-9156",

publisher = "Mary Ann/Liebert, Inc. Publishers",

number = "s2",

note = "ATTD 2024 - 17th International Conference on Advanced Technologies & Treatments for Diabetes, ATTD 2024 ; Conference date: 06-03-2024 Through 09-03-2024",

url = "https://attd.kenes.com/",

}

TY - ABST

T1 - Co‐administered semaglutide and glucose‐dependent insulinotropic peptide receptor agonist compared with monotherapies and placebo in people with type 2 diabetes: a randomised, dose‐finding, phase 2 trial

AU - Knop, Filip Krag

AU - Cabral, Debora P.

AU - Frias, Juan P

AU - Revanna, Manjunatha

AU - Søndergaard, Anette L.

AU - Aroda, Vanita R

PY - 2024/2

Y1 - 2024/2

U2 - 10.1089/dia.2024.2525.abstracts

DO - 10.1089/dia.2024.2525.abstracts

M3 - Conference abstract in journal

SN - 1520-9156

VL - 26

JO - Diabetes Technology & Therapeutics

JF - Diabetes Technology & Therapeutics

IS - s2

M1 - O023 / #680

T2 - ATTD 2024 - 17th International Conference on Advanced Technologies & Treatments for Diabetes

Y2 - 6 March 2024 through 9 March 2024

ER -